|
Home
|
Home
|
Title
|
Date |
|
Vascular |
Vascular |
Thrombolysis with EKOS® Ultrasound for the Resolution of Arterial and Venous Occlusions Study (TERAS)
|
2008-12-02 18:49:57 |
|
Recent Publications |
Recent Publications |
Could renin inhibition be the next step forward in the treatment of diabetic kidney disease?
|
2008-11-26 19:02:54 |
|
Recent Publications |
Recent Publications |
Elevations in serum creatinine with RAAS blockade: Why isn’t it a sign of kidney injury?
|
2008-11-26 18:25:42 |
|
Recent Publications |
Recent Publications |
Centralized infant formula preparation room in the neonatal intensive care unit reduces incidence of microbial contamination.
|
2008-11-26 17:47:58 |
|
Endocrinology |
Endocrinology |
Teriparatide
|
2008-11-24 22:36:34 |
|
Neurology |
Neurology |
SAMMPRIS
|
2008-11-10 16:17:27 |
|
Recent Publications |
Recent Publications |
The New KDOQI™ guidelines for diabetes and chronic kidney disease.
|
2008-07-25 18:12:36 |
|
Recent Publications |
Recent Publications |
Comparison of Low-Fat Versus Mediterranean-Style Dietary Intervention After First Myocardial Infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial)
|
2008-06-17 23:31:16 |
|
Pediatrics |
Pediatrics |
SAMIS Trial
|
2008-06-16 21:13:00 |
|
Home |
Home |
American College of Cardiology Poster Presentation: Dr. Michael Ring
|
2008-06-06 18:16:11 |
|
Cardiology |
Cardiology |
VentrAssist Left Ventricular Assist Device as Bridge to Transplant
|
2008-05-23 16:51:12 |
|
Cardiology |
Cardiology |
VentrAssist Left Ventricular Assist Device as Destination Therapy (Permanent Implant)
|
2008-05-21 20:24:25 |
|
Cardiology |
Cardiology |
HeartMate II Left Ventricular Assist Device as Destination Therapy (Permanent Implant)
|
2008-05-21 20:14:57 |
|
Documents and Forms |
Documents and Forms |
Credentialing Application
|
2008-05-14 00:44:38 |
|
Home |
Home |
Local Eagles Aeries Support Research at PMRC
|
2008-03-03 20:42:15 |
|
2007 |
2007 |
Protein kinase C [beta] inhibition: the promise for treatment of diabetic nephropathy.
|
2008-01-16 00:17:14 |
|
2007 |
2007 |
Exceptional early blood pressure control rates: The ACCOMPLISH trial
|
2008-01-16 00:10:48 |
|
2007 |
2007 |
Albuminuria Reduction: The Holy Grail for Kidney Protection
|
2008-01-15 23:59:08 |
|
2007 |
2007 |
Do Agents that Block the RAS Truly Offer Renoprotective Effects in Early Stage, Nonproteinuric Nephropathy?
|
2008-01-15 23:48:32 |
|
Home |
Home |
National Institutes of Health Sponsored Research at PMRC
|
2008-01-09 17:09:30 |
|
Home |
Home |
National Diabetes trials conducted at PMRC
|
2007-08-28 22:37:26 |
|
2007 |
2007 |
Metabolic Syndrome in a multi-ethnic sample of school children: Implications for the Pediatric Nurse
|
2007-07-23 20:03:20 |
|
2006 |
2006 |
A Causal Role for Uric Acid in Fructose-induced metabolic syndrome
|
2007-07-23 19:30:46 |
|
2007 |
2007 |
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease
|
2007-07-23 18:44:37 |
|
2007 |
2007 |
The New K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and CKD
|
2007-07-23 18:37:30 |
|
2006 |
2006 |
Advanced Glycation End Products and Nephrotoxicity of High-Protein Diets
|
2007-07-23 18:31:51 |
|
2006 |
2006 |
Reviewer's perspective of the role of uric acid
|
2007-07-23 18:24:52 |
|
2007 |
2007 |
Effect of Ruboxistaurin on Urinary Transforming Growth Factor-in Patients With Diabetic Nephropathy and Type 2 Diabetes
|
2007-07-20 19:30:29 |
|
2007 |
2007 |
Kidney Outcomes in Long-Term Studies of Ruboxistaurin for Diabetic Eye Disease
|
2007-07-20 19:21:44 |
|
Vascular |
Vascular |
Vascular Carotid Studies
|
2007-07-03 20:54:06 |
|
In the Spotlight |
In the Spotlight |
PMRC enrolling patients in National Stroke Trial
|
2007-06-25 16:58:13 |
|
Documents and Forms |
Documents and Forms |
FDA Financial Disclosure Form
|
2007-04-20 19:30:03 |
|
Home |
Home |
PMRC now enrolling for National Arterial Vascular Disease Research Trial (click to read more)
|
2007-03-28 16:51:55 |
|
Diabetes |
Diabetes |
Type 1 Diabetes Genetic Consortium (T1DGC)
|
2007-03-09 19:34:15 |
|
Vascular |
Vascular |
Vascular
|
2007-03-07 01:03:44 |
|
About Us |
About Us |
Make a Gift!
|
2007-03-05 23:49:20 |
|
Home |
Home |
PMRC Center Director Co-Chair of National Committee
|
2007-02-23 17:18:41 |
|
Recent Publications |
Recent Publications |
Recent Publications
|
2007-02-19 20:48:44 |
|
Humanitarian Use Devices |
Humanitarian Use Devices |
Humanitarian Use Devices
|
2007-02-19 20:46:17 |
|
Transplant |
Transplant |
Transplant
|
2007-01-12 19:50:34 |
|
Pulmonary |
Pulmonary |
Pulmonary
|
2007-01-12 19:49:18 |
|
Pediatrics |
Pediatrics |
Pediatrics
|
2007-01-12 19:47:05 |
|
Nutrition |
Nutrition |
Nutrition
|
2007-01-12 19:43:51 |
|
Neurology |
Neurology |
Neurology
|
2007-01-12 19:41:33 |
|
Interventional Radiology |
Interventional Radiology |
Interventional Radiology
|
2007-01-12 19:28:59 |
|
Endocrinology |
Endocrinology |
Endocrinology
|
2007-01-12 19:27:40 |
|
Diabetes |
Diabetes |
Diabetes
|
2007-01-12 19:26:16 |
|
About Us |
About Us |
Director
|
2007-01-09 02:28:12 |
|
2001 |
2001 |
GUSTO V: The bottom line of fibrinolytic reperfusion therapy.
|
2006-12-06 22:14:09 |
|
2001 |
2001 |
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial
|
2006-12-06 22:13:23 |
|
2001 |
2001 |
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
|
2006-12-06 22:12:39 |
|
2001 |
2001 |
Characteristics of 1514 Hypertensive patients at high coronary risk, The VALUE Trial.
|
2006-12-06 22:10:56 |
|
2001 |
2001 |
Grapefruit juice-drug interactions: Not just pulp fiction
|
2006-12-06 22:10:09 |
|
2001 |
2001 |
Doefetilide: A new Class III antiarrhythmic for the management of atrial fibrillation.
|
2006-12-06 22:09:17 |
|
2001 |
2001 |
Ischemic nephropathy.
|
2006-12-06 22:00:30 |
|
2001 |
2001 |
Sex differences in uric acid and risk factors for coronary artery disease.
|
2006-12-06 21:59:32 |
|
2001 |
2001 |
Ask the Experts: Please review the mechanisms of the anticoagulant and antithrombotic medications used in the treatment of acute coronary syndrome (ACA).
|
2006-12-06 21:58:35 |
|
2002 |
2002 |
Effects of amino acids and glucose on mesangial cell aminopeptidase A and angiotensin receptors
|
2006-12-06 21:57:43 |
|
2002 |
2002 |
Effect of amino acids and glucagon on renal hemodynamics in type 1 diabetes.
|
2006-12-06 21:56:46 |
|
2002 |
2002 |
Renal parenchymal injury as a determinant of clinical consequences in atherosclerotic renal artery stenosis
|
2006-12-06 21:55:17 |
|
2003 |
2003 |
Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient
|
2006-12-06 21:54:15 |
|
2003 |
2003 |
Provision of pharmacy services to underserved populations via remote dispensing and two-way video conferencing
|
2006-12-06 21:53:35 |
|
2003 |
2003 |
Predictors of acute renal failure after cardiac surgical procedures.
|
2006-12-06 21:52:37 |
|
2003 |
2003 |
Is there a pathogenic role for uric acid in hypertension, cardiovascular, and renal disease?
|
2006-12-06 21:51:43 |
|
2003 |
2003 |
Amino acids induce indicators of response to injury in glomerular mesangial cells.
|
2006-12-06 21:50:30 |
|
2003 |
2003 |
A novel potential therapy for diabetic nephropathy and vascular complications: Protein kinase C beta inhibition
|
2006-12-06 21:49:35 |
|
2004 |
2004 |
Cooking improved my quality of life as a CKD patient
|
2006-12-06 21:48:16 |
|
2004 |
2004 |
Atherosclerotic renal artery stenosis: Current status and future directions.
|
2006-12-06 21:47:31 |
|
2004 |
2004 |
Diabetic nephropathy: Implications for renal and cardiovascular outcomes.
|
2006-12-06 21:46:43 |
|
2004 |
2004 |
National Kidney Foundation - Kidney Disease Outcomes Quality Initiative (K/DOQI ) Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease.
|
2006-12-06 21:45:53 |
|
2004 |
2004 |
Cardiovascular implications of albuminuria.
|
2006-12-06 21:44:47 |
|
2004 |
2004 |
Primary hyperparathyroidism
|
2006-12-06 21:43:58 |
|
2005 |
2005 |
The next generation of diabetic nephropathy therapies: An update.
|
2006-12-06 20:20:52 |
|
2005 |
2005 |
A 60-year-old man with type 2 diabetes, hypertension, dyslipidemia, and albuminuria.
|
2006-12-06 20:14:46 |
|
2005 |
2005 |
The evaluation of diabetic nephropathy: Preventing complications.Johns Hopkins University School of Medicine.
|
2006-12-06 20:11:22 |
|
2005 |
2005 |
Uric Acid, microalbuminuria and cardiovascular events in high-risk patients.
|
2006-12-06 19:59:01 |
|
2005 |
2005 |
Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: A statistical modeling perspective.
|
2006-12-06 19:48:07 |
|
2005 |
2005 |
Renal manifestations of the metabolic syndrome.
|
2006-12-06 19:43:18 |
|
2005 |
2005 |
Cross specialty management of diabetic patients.
|
2006-12-06 19:27:31 |
|
2005 |
2005 |
Amino acid-induced protein kinase C activation and advanced glycation end-products formation in mesangial cells: Non-oxidant mechanisms.
|
2006-12-06 19:26:40 |
|
2006 |
2006 |
Major risks indicators for diabetic kidney disease
|
2006-12-06 19:20:13 |
|
2005 |
2005 |
Renal manifestations of the metabolic syndrome
|
2006-12-04 21:38:16 |
|
2005 |
2005 |
Cross specialty management of diabetic patients. Supplement to Diabetic Microvascular Complications Today 2005.
|
2006-12-04 21:14:10 |
|
- |
- |
Major risks indicators for diabetic kidney disease. In textbook Contemporary Diabetes: The Diabetic Kidney
|
2006-12-04 21:13:01 |
|
Vascular |
Vascular |
CLEVER: Claudication: Exercise vs Endoluminal Revascularization
|
2006-11-28 19:09:02 |
|
Cardiology |
Cardiology |
ATLAS WORKHORSE: A multi-center, single-arm study of the TAXUS Liberte'-SR stent for the treatment of patients with de novo coronary artery lesions
|
2006-11-27 20:40:50 |
|
Cardiology |
Cardiology |
Cardiology
|
2006-11-07 23:25:20 |
|
Nephrology and Hypertension |
Nephrology and Hypertension |
Nephrology and Hypertension
|
2006-11-07 21:14:19 |
|
Cardiology |
Cardiology |
COSTAR CObalt chromium STent with Antiproliferative for Restenosis II Trial (The COSTAR II Trial)
|
2006-11-06 18:05:12 |
|
2002 |
2002 |
Effects of amino acids and glucose on mesangial cell aminopeptidase a and angiotensin receptors
|
2006-11-01 20:33:54 |
|
2003 |
2003 |
Amino acids induce indicators of response to injury in glomerular mesangial cells
|
2006-11-01 20:28:45 |
|
2005 |
2005 |
Amino acids injure mesangial cells by advanced glycation end products, oxidative stress and protein kinase C
|
2006-11-01 19:44:37 |
|
2005 |
2005 |
Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome
|
2006-10-31 21:58:01 |
|
Cardiology |
Cardiology |
ENDEAVOR III: A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions
|
2006-10-31 21:34:56 |
|
2005 |
2005 |
Diabetic Kidney Disease: A review of the science.
|
2006-10-31 20:48:32 |
|
Documents and Forms |
Documents and Forms |
General Information to Investigators
|
2006-10-31 06:36:41 |
|
Documents and Forms |
Documents and Forms |
Clinical Trial Application Form
|
2006-10-31 06:33:33 |
|
2005 |
2005 |
A causal role for uric acid in fructose-induced metabolic syndrome
|
2006-10-30 19:55:52 |
|
2006 |
2006 |
New KDOQI Guidelines for Diabetes and CKD
|
2006-10-30 19:52:54 |
|
Nephrology and Hypertension |
Nephrology and Hypertension |
SHARP: Study of Heart and Renal Protection
|
2006-10-27 20:04:56 |
|
2006 |
2006 |
Accepted Presentation: American Diabetes Association 66th Scientific Sessions Annual Meeting June 2006, Washington DC.
|
2006-10-24 19:55:13 |
|
2005 |
2005 |
Linking Metabolism and Immunology: Diabetic Nephropathy Is an Inflammatory Disease
|
2006-10-24 19:42:53 |
|
Basic Sciences Lab |
Basic Sciences Lab |
Basic Sciences Lab
|
2006-10-18 22:21:24 |
|
Cardiology |
Cardiology |
CLOSURE I :
|
2006-10-18 20:01:49 |
|
Neurology |
Neurology |
IRIS
|
2006-10-18 19:40:02 |
|
Vascular |
Vascular |
ZILVER PTX
|
2006-10-18 19:35:56 |
|
Diabetes |
Diabetes |
Natural History Study of the Development of Type 1 Diabetes.
|
2006-10-18 17:44:06 |
|
Vascular |
Vascular |
CREST
|
2006-10-18 17:37:22 |
|
Nephrology and Hypertension |
Nephrology and Hypertension |
CORAL : Cardiovascular Outcomes in Renal Atherosclerosis (CORAL)
|
2006-10-18 17:18:32 |
|
Pulmonary |
Pulmonary |
BioSeal-Lung Biopsy Tract Plug Study
|
2006-10-18 17:13:26 |
|
Transplant |
Transplant |
BENEFIT and BENEFIT EXT
|
2006-10-18 16:56:30 |
|
Vascular |
Vascular |
PIVOTAL: Positive Impact of Endovascular Options for Treating Aneurysms Early
|
2006-10-17 22:19:40 |
|
Cardiology |
Cardiology |
Early Anticoagulation Regime Comparison in the Medtronic Mosaic Bioprosthesis
|
2006-10-17 21:56:53 |
|
In the Spotlight |
In the Spotlight |
Providence Research Chosen as National Research Site
|
2006-10-17 21:19:03 |
|
2006 |
2006 |
Journal of Renal Nutrition
|
2006-10-17 02:50:30 |
|
About Us |
About Us |
View Our Annual Report
|
2006-10-06 18:57:30 |
|
About Us |
About Us |
Maps and Directions
|
2006-10-05 22:52:20 |
|
About Us |
About Us |
Contact Us
|
2006-10-05 22:50:21 |
|
Areas of Research |
Areas of Research |
Areas of Research
|
2006-10-05 22:03:17 |
|
About Us |
About Us |
About Us
|
2006-10-05 22:01:47 |
|
Health Care Professionals |
Health Care Professionals |
Health Care Professionals
|
2006-10-05 21:46:44 |
|
Patients and Families |
Patients and Families |
Patients and Families
|
2006-10-05 21:45:03 |
|
About Us |
About Us |
Research Highlights
|
2006-10-05 21:39:01 |
|
Sponsors |
Sponsors |
Information for Study Sponsors
|
2006-10-05 21:34:55 |
|
About Us |
About Us |
Our Staff
|
2006-10-05 21:32:07 |